COMMUNIQUÉS West-GlobeNewswire

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

22/07/2024 - 14:10

Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th [...]

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

22/07/2024 - 14:03

The Company will Host a Conference Call and Webcast on Thursday, August 8, 2024, at 8:30 AM ET CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX [...]

Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024

22/07/2024 - 14:00

Oxford, UK and San Jose, California, 22 July 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, announces it has [...]

UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer

22/07/2024 - 14:00

SAN FRANCISCO, July 22, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced the [...]

DLH to Announce Fiscal 2024 Third Quarter Financial Results

22/07/2024 - 14:00

ATLANTA, July 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]

AnewHealth Announces Strategic Investment from The Vistria Group and Acquisition of HomeFree

22/07/2024 - 14:00

AnewHealth will merge HomeFree with its national medication management and pharmacy provider, ExactCare, to further amplify its focus on improving clinical and cost outcomes for the most complex patients in healthcare [...]

Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer

22/07/2024 - 14:00

MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL

22/07/2024 - 14:00

WESTLAKE VILLAGE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures

20/07/2024 - 22:11

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a New York, USA-based company researching stem cells in order to develop new cell therapies unlocked $1.75 million additional funds from SOSV and the [...]

The Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer Passes $100 Million Milestone in its 16th Year

20/07/2024 - 15:45

Over $7.3 million raised this year alone for Albertans facing cancer in Alberta’s largest cycling fundraiser STRATHMORE, Alberta, July 20, 2024 (GLOBE NEWSWIRE) -- Today, over 1,400 cyclists and their supporters are [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

19/07/2024 - 23:00

SAN CARLOS, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]

Aptose Announces Receipt of Deficiency Notice from Nasdaq

19/07/2024 - 23:00

SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

19/07/2024 - 22:15

Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosis At three months post procedure, [...]

IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process

19/07/2024 - 22:05

MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OTC: IGXT) , a leading drug delivery company focused on the development and manufacturing of pharmaceutical [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

19/07/2024 - 22:05

NOVATO, Calif., July 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

19/07/2024 - 22:05

MIAMI, July 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening [...]

Transparency Notifications from Shareholders

19/07/2024 - 18:30

Transparency Notifications from Shareholders PRESS RELEASE REGULATED INFORMATION 19 July 2024, 06:30 pm CEST Ghent, Belgium – 19 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana [...]

BioSenic S.A. : Transparency notification received from Mr François Rieger

19/07/2024 - 18:00

PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, July 19, 2024, 6pm CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical [...]

BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger

19/07/2024 - 18:00

COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 19 juillet 2024 à 18h00 CEST – BIOSENIC (Euronext [...]